TABLE 1

SB in All Striatal Regions, Ratios, and Absolute Lateralization Indices in Patients with IPS and Non-IPS

IPSNon-IPSSensitivity (%)Specificity (%)Accuracy (%)
Binding and regionMean ± SDRangeMean ± SDRangePROC (AUC ± SE)NPV (%)PPV (%)
Dopamine D2/3–specific binding
 Striatum2.16 ± 0.321.52–2.961.55 ± 0.280.86–2.00<0.0010.936 ± 0.02786.590.988.988.988.9
 Caudate nucleus1.91 ± 0.321.23–2.661.48 ± 0.250.84–1.98<0.0010.859 ± 0.04173.086.479.281.880.2
 Putamen2.23 ± 0.331.60–3.041.57 ± 0.310.79–2.08<0.0010.944 ± 0.02486.593.289.191.490.1
 Anterior putamen2.12 ± 0.311.54–2.971.62 ± 0.281.00–2.12<0.0010.894 ± 0.03683.886.486.483.885.2
 Posterior putamen2.42 ± 0.391.67–3.311.49 ± 0.420.46–2.13<0.0010.970 ± 0.01686.595.589.494.191.4
P-to-NC ratio1.18 ± 0.101.07 ± 0.20<0.010.690 ± 0.05881.147.775.056.663.0
PP-to-NC ratio1.27 ± 0.131.02 ± 0.28<0.0010.830 ± 0.04581.175.082.573.277.8
PP-to-PA ratio1.14 ± 0.090.91 ± 0.18<0.0010.907 ± 0.03283.881.885.779.582.7
Combination SBPP and PP-to-PA ratio97.384.197.483.790.1
ALI
 Striatum0.05 ± 0.040.10 ± 0.10<0.010.372 ± 0.06245.943.248.740.544.4
 Caudate nucleus0.08 ± 0.070.10 ± 0.06>0.050.357 ± 0.06362.220.539.139.739.5
 Anterior putamen0.05 ± 0.030.10 ± 0.11<0.010.329 ± 0.05975.711.435.741.840.7
 Posterior putamen0.08 ± 0.060.17 ± 0.18<0.010.340 ± 0.06086.511.450.045.145.7
Discriminant analysis (SBPP, PP-to-PA ratio, and PP-to-NC ratio)91.995.593.394.493.8
  • Level of significance from Student t test (P); AUC with respective SE from ROC analysis; and sensitivity, specificity, NPV, PPV, and accuracy for optimal specific binding threshold are presented.